Comparative Efficacy and Safety of Triple Therapy (Ramipril, Telmisartan, Hydrochlorothiazide) Vs Dual Anti Hypertensive Therapy (Ramipril or Telmisartan, Hydrochlorothiazide) in Stage 2 Hypertensive Patients

Aim: To evaluate the comparative efficacy and safety of ramipril 5mg plus hydrochlorothiazide 12.5mg (R + HCTZ), telmisartan 40mg plus hydrochlorothiazide12.5mg (T + HCTZ) and ramipril 2.5mg plus telmisartan 20mg plus hydrochlorothiazide12.5mg (R + T + HCTZ) in patients with stage 2 hypertension. Ma...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bhushan, Bharat, Gupta, Seema, Khajuria, Vijay, Kumar, Dinesh, Lal, Mohan, Kumar, Dharminder, Bhat, Sanjeev, Sharma, Aman
Format: Artigo
Langue:Inglês
Publié: JCDR Research and Publications (P) Limited 2014
Sujets:
Pharmacology Section
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190738/
https://ncbi.nlm.nih.gov/pubmed/25302216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/8851.4720
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires